{"id":"NCT03492281","sponsor":"Urovant Sciences GmbH","briefTitle":"A Study to Examine the Safety and Efficacy of a New Drug in Patients With Symptoms of Overactive Bladder (OAB)","officialTitle":"An International Phase 3, Randomized, Double-Blind, Placebo- and Active (Tolterodine)-Controlled Multicenter Study to Evaluate the Safety and Efficacy of Vibegron in Patients With Symptoms of Overactive Bladder","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-03-26","primaryCompletion":"2019-01-10","completion":"2019-02-04","firstPosted":"2018-04-10","resultsPosted":"2021-03-04","lastUpdate":"2021-03-04"},"enrollment":1530,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Overactive Bladder"],"interventions":[{"type":"DRUG","name":"vibegron","otherNames":["RVT-901","MK4618","KRP114V","URO-901"]},{"type":"DRUG","name":"Vibegron placebo","otherNames":[]},{"type":"DRUG","name":"Tolterodine Tartrate ER","otherNames":["Mariosea XL"]},{"type":"DRUG","name":"Tolterodine placebo","otherNames":[]}],"arms":[{"label":"Vibegron + Placebo to match Tolterodine","type":"EXPERIMENTAL"},{"label":"Placebo to match vibegron + Placebo to match Tolterodine","type":"PLACEBO_COMPARATOR"},{"label":"Tolterodine + Placebo to match vibegron","type":"ACTIVE_COMPARATOR"}],"summary":"This study is designed to evaluate the safety, tolerability, and efficacy of vibegron administered once daily in patients with OAB.","primaryOutcome":{"measure":"Change From Baseline (CFB) at Week 12 in the Average Number of Micturitions Per 24 Hours in All Overactive Bladder (OAB) Participants","timeFrame":"Baseline (BL); Week 12","effectByArm":[{"arm":"Placebo","deltaMin":-1.3,"sd":0.14},{"arm":"Vibegron 75 mg","deltaMin":-1.8,"sd":0.14},{"arm":"Tolterodine ER 4 mg","deltaMin":-1.6,"sd":0.15}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"},{"comp":"OG000 vs OG002","p":"=0.0988"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":215,"countries":["United States","Canada","Hungary","Latvia","Lithuania","Poland"]},"refs":{"pmids":["37586057","37586052","37160401","36384907","35685566","34921665","33469832","33332699"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":6,"n":540},"commonTop":["Urinary tract infection","Dry mouth"]}}